Continuous Medicaid Coverage Essential for People Living With HIV
The strongest association with viral suppression after Medicaid gap was viral suppression before Medicaid gap.
Several studies have determined that PLWHIV have a higher risk for 30-day readmission than the general population.
Dolutegravir monotherapy was noninferior to combination antiretroviral therapy (cART) in patients who started cART during primary HIV infection.
Because of high risk for virologic failure and of the emergence of INSTI resistance, dolutegravir monotherapy should be avoided as a maintenance strategy.